Neuromedin U receptors in GtoPdb v.2023.1
暂无分享,去创建一个
A. Howard | J. Hedrick | G. Willars | N. Semjonous | P. Jethwa | R. Raddatz | S. Luckman | S. Bloom | Khaled A. Al‐Hosaini
[1] K. Mori,et al. Design and synthesis of peptidic partial agonists of human neuromedin U receptor 1 with enhanced serum stability. , 2020, Bioorganic & Medicinal Chemistry Letters.
[2] K. Mori,et al. A chemically stable peptide agonist to neuromedin U receptor type 2. , 2020, Bioorganic & Medicinal Chemistry.
[3] Peter Buneman,et al. Why data citation isn't working, and what to do about it , 2020, Database J. Biol. Databases Curation.
[4] M. Miyazato,et al. Purification and identification of native forms of goldfish neuromedin U from brain and gut. , 2019, Biochemical and biophysical research communications.
[5] N. Anastasio,et al. Binge-Type Eating in Rats is Facilitated by Neuromedin U Receptor 2 in the Nucleus Accumbens and Ventral Tegmental Area , 2019, Nutrients.
[6] Jonathan D. Hommel,et al. Incubation of feeding behavior is regulated by neuromedin U receptor 2 in the paraventricular nucleus of the hypothalamus , 2018, Behavioural Brain Research.
[7] Lei Gao,et al. Identification of NMU as a potential gene conferring alectinib resistance in non-small cell lung cancer based on bioinformatics analyses. , 2018, Gene.
[8] J. Hommel,et al. Cocaine-Evoked Locomotor Activity Negatively Correlates With the Expression of Neuromedin U Receptor 2 in the Nucleus Accumbens , 2018, Front. Behav. Neurosci..
[9] Na Ye,et al. Small‐Molecule Neuromedin U Receptor 2 Agonists Suppress Food Intake and Decrease Visceral Fat in Animal Models , 2018, Pharmacology research & perspectives.
[10] K. Nakao,et al. Role of neuromedin U in accelerating of non-alcoholic steatohepatitis in mice , 2018, Peptides.
[11] J. Noguchi,et al. PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration , 2017, Peptides.
[12] H. Hirabayashi,et al. Potent Body Weight-Lowering Effect of a Neuromedin U Receptor 2-selective PEGylated Peptide. , 2017, Journal of medicinal chemistry.
[13] K. Mori,et al. Discovery of a Human Neuromedin U Receptor 1-Selective Hexapeptide Agonist with Enhanced Serum Stability. , 2017, Journal of medicinal chemistry.
[14] B. Patel,et al. Neuromedin: An insight into its types, receptors and therapeutic opportunities , 2017, Pharmacological reports : PR.
[15] T. Shinohara,et al. A PEGylated analog of short-length Neuromedin U with potent anorectic and anti-obesity effects. , 2017, Bioorganic & medicinal chemistry.
[16] E. Dahl,et al. Oncogenic features of neuromedin U in breast cancer are associated with NMUR2 expression involving crosstalk with members of the WNT signaling pathway , 2017, Oncotarget.
[17] E. Egecioglu,et al. Central administration of the anorexigenic peptide neuromedin U decreases alcohol intake and attenuates alcohol‐induced reward in rodents , 2016, Addiction biology.
[18] H. Meltzer,et al. Gamma-Aminobutyric Acidergic Projections From the Dorsal Raphe to the Nucleus Accumbens Are Regulated by Neuromedin U , 2016, Biological Psychiatry.
[19] Y. Hayashi,et al. Identification of a degrading enzyme in human serum that hydrolyzes a C‐terminal core sequence of neuromedin U , 2016, Biopolymers.
[20] E. Jerlhag,et al. The Anorexigenic Peptide Neuromedin U (NMU) Attenuates Amphetamine-Induced Locomotor Stimulation, Accumbal Dopamine Release and Expression of Conditioned Place Preference in Mice , 2016, PloS one.
[21] K. Mori,et al. Involvement of endogenous neuromedin U and neuromedin S in thermoregulation. , 2016, Biochemical and biophysical research communications.
[22] A. Schier,et al. A Zebrafish Genetic Screen Identifies Neuromedin U as a Regulator of Sleep/Wake States , 2016, Neuron.
[23] Zhongyou Li,et al. NMU signaling promotes endometrial cancer cell progression by modulating adhesion signaling , 2016, Oncotarget.
[24] A. Waring,et al. Small lipidated anti-obesity compounds derived from neuromedin U. , 2015, European journal of medicinal chemistry.
[25] C. Luo,et al. Identifying a Neuromedin U Receptor 2 Splice Variant and Determining Its Roles in the Regulation of Signaling and Tumorigenesis In Vitro , 2015, PloS one.
[26] J. Jelsing,et al. A Hamster Model of Diet-Induced Obesity for Preclinical Evaluation of Anti-Obesity, Anti-Diabetic and Lipid Modulating Agents , 2015, PloS one.
[27] K. Mori,et al. Discovery of potent hexapeptide agonists to human neuromedin u receptor 1 and identification of their serum metabolites. , 2015, ACS medicinal chemistry letters.
[28] Ling Zhang,et al. Design, synthesis and biological activity of flavonoid derivatives as selective agonists for neuromedin U 2 receptor. , 2014, Bioorganic & medicinal chemistry.
[29] K. Mori,et al. Discovery of selective hexapeptide agonists to human neuromedin U receptors types 1 and 2. , 2014, Journal of medicinal chemistry.
[30] L. O’Driscoll,et al. Neuromedin U: a candidate biomarker and therapeutic target to predict and overcome resistance to HER-tyrosine kinase inhibitors. , 2014, Cancer research.
[31] Lixia Guo,et al. p-Synephrine: a novel agonist for neuromedin U2 receptor. , 2014, Biological & pharmaceutical bulletin.
[32] G. Telegdy,et al. Neurotransmissions of antidepressant-like effects of neuromedin U-23 in mice , 2014, Behavioural Brain Research.
[33] Jonathan D. Hommel,et al. Neuromedin U receptor 2 knockdown in the paraventricular nucleus modifies behavioral responses to obesogenic high-fat food and leads to increased body weight , 2014, Neuroscience.
[34] A. Peier,et al. Development of a neuromedin U–human serum albumin conjugate as a long‐acting candidate for the treatment of obesity and diabetes. Comparison with the PEGylated peptide , 2014, Journal of peptide science : an official publication of the European Peptide Society.
[35] G. Telegdy,et al. Anxiolytic action of neuromedin-U and neurotransmitters involved in mice , 2013, Regulatory Peptides.
[36] W. Ahrens,et al. Understanding the Links among neuromedin U Gene, beta2-adrenoceptor Gene and Bone Health: An Observational Study in European Children , 2013, PloS one.
[37] I. Sakata,et al. Negative Regulation of Neuromedin U mRNA Expression in the Rat Pars Tuberalis by Melatonin , 2013, PloS one.
[38] A. Peier,et al. PEGylation of Neuromedin U yields a promising candidate for the treatment of obesity and diabetes. , 2012, Bioorganic & medicinal chemistry.
[39] F. Liu,et al. Neuromedin S Increases L-type Ca2+ Channel Currents Through Giα-protein and Phospholipase C-dependent Novel Protein Kinase C Delta Pathway in Adult Rat Ventricular Myocytes , 2012, Cellular Physiology and Biochemistry.
[40] Yuan Zhang,et al. Neuromedin U Type 1 Receptor Stimulation of A-type K+ Current Requires the βγ Subunits of Go Protein, Protein Kinase A, and Extracellular Signal-regulated Kinase 1/2 (ERK1/2) in Sensory Neurons* , 2012, The Journal of Biological Chemistry.
[41] R. Weissleder,et al. The neuropeptide neuromedin U promotes autoantibody-mediated arthritis , 2012, Arthritis Research & Therapy.
[42] S. Purcell,et al. Confirmation of prior evidence of genetic susceptibility to alcoholism in a genome-wide association study of comorbid alcoholism and bipolar disorder , 2011, Psychiatric genetics.
[43] P. Pilowsky,et al. Intrathecal neuromedin U induces biphasic effects on sympathetic vasomotor tone, increases respiratory drive and attenuates sympathetic reflexes in rat , 2011, British journal of pharmacology.
[44] A. Peier,et al. Effects of peripherally administered neuromedin U on energy and glucose homeostasis. , 2011, Endocrinology.
[45] Joanna L. Sharman,et al. IUPHAR-DB: new receptors and tools for easy searching and visualization of pharmacological data , 2010, Nucleic Acids Res..
[46] Juan Su,et al. The regulatory mechanism of neuromedin S on luteinizing hormone in pigs. , 2010, Animal reproduction science.
[47] K. Mori,et al. Comparison of feeding suppression by the anorexigenic hormones neuromedin U and neuromedin S in rats. , 2010, The Journal of endocrinology.
[48] M. Fujimiya,et al. Centrally administered neuromedin S inhibits feeding behavior and gastroduodenal motility in mice. , 2010, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[49] N. Andersson,et al. Central NMU signaling in body weight and energy balance regulation: evidence from NMUR2 deletion and chronic central NMU treatment in mice. , 2009, American journal of physiology. Endocrinology and metabolism.
[50] A. Peier,et al. The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2). , 2009, Endocrinology.
[51] S. Trivedi,et al. Discovery and Pharmacological Characterization of a Small-Molecule Antagonist at Neuromedin U Receptor NMUR2 , 2009, Journal of Pharmacology and Experimental Therapeutics.
[52] D. Bechtold,et al. Appetite-modifying actions of pro-neuromedin U-derived peptides , 2009, American journal of physiology. Endocrinology and metabolism.
[53] J. Hoheisel,et al. Neuromedin U is overexpressed in pancreatic cancer and increases invasiveness via the hepatocyte growth factor c-Met pathway. , 2009, Cancer letters.
[54] M. Sassek,et al. Does Somatostatin Confer Insulinostatic Effects of Neuromedin U in the Rat Pancreas? , 2009, Pancreas.
[55] K. Nagai,et al. Autonomic and cardiovascular effects of central neuromedin U in rats , 2009, Physiology & Behavior.
[56] A. Davenport,et al. Expression and vasoconstrictor function of anorexigenic peptides neuromedin U-25 and S in the human cardiovascular system. , 2008, Cardiovascular research.
[57] K. Mori,et al. Involvement of neuromedin S in the oxytocin release response to suckling stimulus. , 2008, Biochemical and biophysical research communications.
[58] C. Binkert,et al. Distribution of neuromedin U binding sites in the rat CNS revealed by in vitro receptor autoradiography , 2008, Neuropeptides.
[59] G. Nussdorfer,et al. Neuromedin-U stimulates enucleation-induced adrenocortical regeneration in the rat. , 2008, International journal of molecular medicine.
[60] A. Wise,et al. Paradoxical Behavior of Neuromedin U in Isolated Smooth Muscle Cells and Intact Tissue , 2008, Journal of Pharmacology and Experimental Therapeutics.
[61] H. Su,et al. Identification of non-peptidic neuromedin U receptor modulators by a robust homogeneous screening assay , 2008, Acta Pharmacologica Sinica.
[62] J A Peters,et al. Guide to Receptors and Channels (GRAC), 3rd edition , 2008, British journal of pharmacology.
[63] A. Ziółkowska,et al. Effects of neuromedin-U on immature rat adrenocortical cells: in vitro and in vivo studies. , 2008, International journal of molecular medicine.
[64] K. Mori,et al. Identification and functional analysis of a novel ligand for G protein-coupled receptor, Neuromedin S , 2008, Regulatory Peptides.
[65] S. Shioda,et al. Isolation and Characterisation of Four cDNAs Encoding Neuromedin U (NMU) From the Brain and Gut of Goldfish, and the Inhibitory Effect of a Deduced NMU on Food Intake and Locomotor Activity , 2007, Journal of neuroendocrinology.
[66] K. Mori,et al. Neuromedin S: discovery and functions. , 2008, Results and problems in cell differentiation.
[67] A. Ziółkowska,et al. Neuromedin U directly stimulates growth of cultured rat calvarial osteoblast-like cells acting via the NMU receptor 2 isoform. , 2008, International journal of molecular medicine.
[68] G. Telegdy,et al. Endocrine and behavioral effects of neuromedin S , 2007, Hormones and Behavior.
[69] C. Luo,et al. Molecular dissection of G protein preference using Gsalpha chimeras reveals novel ligand signaling of GPCRs. , 2007, American journal of physiology. Endocrinology and metabolism.
[70] Takahiro Matsumoto,et al. Central control of bone remodeling by neuromedin U , 2007, Nature Medicine.
[71] D. Theodorescu,et al. RhoGDI2: a new metastasis suppressor gene: discovery and clinical translation. , 2007, Urologic oncology.
[72] A. Murphy,et al. Mice genetically deficient in neuromedin U receptor 2, but not neuromedin U receptor 1, have impaired nociceptive responses , 2007, PAIN.
[73] A. Ziółkowska,et al. Expression of neuromedins S and U and their receptors in the hypothalamus and endocrine glands of the rat. , 2007, International journal of molecular medicine.
[74] K. Sugahara,et al. Central administration of neuromedin U suppresses food intake in chicks , 2007, Neuroscience Letters.
[75] Valérie Capra,et al. The Highly Conserved DRY Motif of Class A G Protein-Coupled Receptors: Beyond the Ground State , 2007, Molecular Pharmacology.
[76] G. Sanger,et al. Neuromedin U can exert colon‐specific, enteric nerve‐mediated prokinetic activity, via a pathway involving NMU1 receptor activation , 2007, British journal of pharmacology.
[77] H. Frierson,et al. Neuromedin U is regulated by the metastasis suppressor RhoGDI2 and is a novel promoter of tumor formation, lung metastasis and cancer cachexia , 2007, Oncogene.
[78] M. Tena-Sempere,et al. Neuromedin s as novel putative regulator of luteinizing hormone secretion. , 2007, Endocrinology.
[79] K. Murao,et al. Central administration of neuromedin U activates neurons in ventrobasal hypothalamus and brainstem , 2001, Endocrine.
[80] Tatiana Foroud,et al. Pooled association genome scanning for alcohol dependence using 104,268 SNPs: Validation and use to identify alcoholism vulnerability loci in unrelated individuals from the collaborative study on the genetics of alcoholism , 2006, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[81] T. Hansen,et al. Association between neuromedin U gene variants and overweight and obesity. , 2006, The Journal of clinical endocrinology and metabolism.
[82] L. Malendowicz,et al. Neuromedin U receptor 1 expression in the rat endocrine pancreas and evidence suggesting neuromedin U suppressive effect on insulin secretion from isolated rat pancreatic islets. , 2006, International journal of molecular medicine.
[83] J. Hohmann,et al. Neuromedin U Receptor 2-Deficient Mice Display Differential Responses in Sensory Perception, Stress, and Feeding , 2006, Molecular and Cellular Biology.
[84] Yusuke Nakamura,et al. The neuromedin U-growth hormone secretagogue receptor 1b/neurotensin receptor 1 oncogenic signaling pathway as a therapeutic target for lung cancer. , 2006, Cancer research.
[85] N. Shankley,et al. Neuromedin U stimulates contraction of human long saphenous vein and gastrointestinal smooth muscle in vitro , 2006, Regulatory Peptides.
[86] K. Mori,et al. Structural and functional analogs of the novel mammalian neuropeptide, neuromedin S (NmS), in the dermal venoms of Eurasian bombinid toads. , 2006, Biochemical and biophysical research communications.
[87] Takahiro Sato,et al. Regulation of gonadotropin secretion and puberty onset by neuromedin U , 2006, FEBS letters.
[88] S. Bloom,et al. Neuromedin U partially mediates leptin-induced hypothalamo-pituitary adrenal (HPA) stimulation and has a physiological role in the regulation of the HPA axis in the rat. , 2006, Endocrinology.
[89] A. Yoshimura,et al. The neuropeptide neuromedin U activates eosinophils and is involved in allergen-induced eosinophilia. , 2006, American journal of physiology. Lung cellular and molecular physiology.
[90] N. Shankley,et al. Species‐dependent smooth muscle contraction to Neuromedin U and determination of the receptor subtypes mediating contraction using NMU1 receptor knockout mice , 2006, British journal of pharmacology.
[91] A. Yoshimura,et al. The neuropeptide neuromedin U promotes IL-6 production from macrophages and endotoxin shock. , 2006, Biochemical and biophysical research communications.
[92] K. Mori,et al. Neuromedin s is a novel anorexigenic hormone. , 2005, Endocrinology.
[93] S. Bloom,et al. Neuromedin U has a physiological role in the regulation of food intake and partially mediates the effects of leptin. , 2005, American journal of physiology. Endocrinology and metabolism.
[94] A. Yoshimura,et al. The neuropeptide neuromedin U promotes inflammation by direct activation of mast cells , 2005, The Journal of experimental medicine.
[95] R. Lai,et al. Identification and molecular cloning of a novel neuromedin U analog from the skin secretions of toad Bombina maxima , 2005, Regulatory Peptides.
[96] Richard R. Neubig,et al. International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List , 2005, Pharmacological Reviews.
[97] T. Kowalski,et al. Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. , 2005, The Journal of endocrinology.
[98] R. Zeillinger,et al. Identification of L1CAM, Jagged2 and Neuromedin U as ovarian cancer-associated antigens. , 2005, Oncology reports.
[99] K. Kangawa,et al. Endogenous neuromedin U has anorectic effects in the Japanese quail. , 2005, General and comparative endocrinology.
[100] P. Morgan,et al. Neuromedin‐U is regulated by the circadian clock in the SCN of the mouse , 2005, The European journal of neuroscience.
[101] K. Mori,et al. Identification of neuromedin S and its possible role in the mammalian circadian oscillator system , 2005, The EMBO journal.
[102] H. Sarau,et al. Neuromedin Elicits Cytokine Release in Murine Th2-Type T Cell Clone D10.G4.1 , 2004, The Journal of Immunology.
[103] P. Szekeres,et al. Signaling and Ligand Binding by Recombinant Neuromedin U Receptors: Evidence for Dual Coupling to Gαq/11 and Gαi and an Irreversible Ligand-Receptor Interaction , 2004, Molecular Pharmacology.
[104] K. Kangawa,et al. Neuromedin U is involved in nociceptive reflexes and adaptation to environmental stimuli in mice. , 2004, Biochemical and biophysical research communications.
[105] N. Martin,et al. Chronic administration of NMU into the paraventricular nucleus stimulates the HPA axis but does not influence food intake or body weight. , 2004, Biochemical and biophysical research communications.
[106] S. Bhattacharyya,et al. Studies of the neuromedin U-2 receptor gene in human obesity: evidence for the existence of two ancestral forms of the receptor. , 2004, The Journal of endocrinology.
[107] M. Ikawa,et al. Neuromedin U has a novel anorexigenic effect independent of the leptin signaling pathway , 2004, Nature Medicine.
[108] A. Gewirtz,et al. Neuromedin U: a Myb-regulated autocrine growth factor for human myeloid leukemias. , 2004, Blood.
[109] H. Sarau,et al. Radioligand Binding and Functional Characterization of Recombinant Human NmU1 and NmU2 Receptors Stably Expressed in Clonal Human Embryonic Kidney-293 Cells , 2004, Pharmacology.
[110] J. Hagan,et al. Localisation of NMU1R and NMU2R in human and rat central nervous system and effects of neuromedin-U following central administration in rats , 2004, Psychopharmacology.
[111] P. Szekeres,et al. Neuromedin U and Its Receptors: Structure, Function, and Physiological Roles , 2004, Pharmacological Reviews.
[112] K. Kangawa,et al. The gut-brain peptide neuromedin U is involved in the mammalian circadian oscillator system. , 2004, Biochemical and biophysical research communications.
[113] J. Polak,et al. Neuromedin U-like immunoreactivity in the thyroid gland of the rat , 1990, Cell and Tissue Research.
[114] P. Barrett,et al. Neuromedin U and Neuromedin U receptor‐2 expression in the mouse and rat hypothalamus: effects of nutritional status , 2003, Journal of neurochemistry.
[115] Y. Kanai,et al. Central actions of neuromedin U via corticotropin-releasing hormone. , 2003, Biochemical and biophysical research communications.
[116] M. Furuta,et al. Effects of neuromedin U on the pulsatile LH secretion in ovariectomized rats in association with feeding conditions. , 2003, Biochemical and biophysical research communications.
[117] A. Dray,et al. Pro-nociceptive effects of neuromedin u in rat , 2003, Neuroscience.
[118] Xiao Hong Yu,et al. A pro-nociceptive role of neuromedin U in adult mice , 2003, Pain.
[119] K. Toshinai,et al. Neuromedin U acts in the central nervous system to inhibit gastric acid secretion via CRH system. , 2003, American journal of physiology. Gastrointestinal and liver physiology.
[120] F. Sato,et al. Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. , 2002, Cancer cell.
[121] M. Nakazato,et al. Centrally administered neuromedin U activates neurosecretion and induction of c-fos messenger ribonucleic acid in the paraventricular and supraoptic nuclei of rat. , 2002, Endocrinology.
[122] C. Lawrence,et al. Printed in U.S.A. Copyright © 2002 by The Endocrine Society doi: 10.1210/en.2002-220121 Evaluation of Neuromedin U Actions in Energy Homeostasis and Pituitary Function , 2022 .
[123] F. Monsma,et al. Cloning and characterization of murine neuromedin U receptors , 2002, Peptides.
[124] J. Hieble,et al. Characterization of neuromedin U effects in canine smooth muscle. , 2002, Journal of Pharmacology and Experimental Therapeutics.
[125] M. Nakazato,et al. Cardiovascular actions of central neuromedin U in conscious rats , 2002, Regulatory Peptides.
[126] S. Bloom,et al. Hypothalamic actions of neuromedin U. , 2002, Endocrinology.
[127] T. Suda,et al. A role for neuromedin U in stress response. , 2001, Biochemical and biophysical research communications.
[128] R. Todd,et al. Oral cancer in vivo gene expression profiling assisted by laser capture microdissection and microarray analysis , 2001, Oncogene.
[129] L. V. D. van der Ploeg,et al. Distribution of neuromedin U receptor subtype 2 mRNA in the rat brain. , 2001, Brain research. Gene expression patterns.
[130] F. Monsma,et al. Identification of a Novel Neuromedin U Receptor Subtype Expressed in the Central Nervous System* , 2000, The Journal of Biological Chemistry.
[131] B. Borowsky,et al. Identification and Characterization of Two Neuromedin U Receptors Differentially Expressed in Peripheral Tissues and the Central Nervous System* , 2000, The Journal of Biological Chemistry.
[132] M. Nakazato,et al. Central effects of neuromedin U in the regulation of energy homeostasis. , 2000, Biochemical and biophysical research communications.
[133] F. Monsma,et al. Identification of a human gastrointestinal tract and immune system receptor for the peptide neuromedin U. , 2000, Molecular pharmacology.
[134] M. Nakazato,et al. Purification and identification of neuromedin U as an endogenous ligand for an orphan receptor GPR66 (FM3). , 2000, Biochemical and biophysical research communications.
[135] H. Matsui,et al. Identification and Functional Characterization of a Novel Subtype of Neuromedin U Receptor* , 2000, The Journal of Biological Chemistry.
[136] O. Nishimura,et al. Identification of Neuromedin U as the Cognate Ligand of the Orphan G Protein-coupled Receptor FM-3* , 2000, The Journal of Biological Chemistry.
[137] J. Chambers,et al. Neuromedin U Is a Potent Agonist at the Orphan G Protein-coupled Receptor FM3* , 2000, The Journal of Biological Chemistry.
[138] Christopher P. Austin,et al. Identification of receptors for neuromedin U and its role in feeding , 2000, Nature.
[139] S. Bloom,et al. Isolation, Structural Characterization, and Bioactivity of a Novel Neuromedin U Analog from the Defensive Skin Secretion of the Australasian Tree Frog, Litoria caerulea * 210 , 2000, The Journal of Biological Chemistry.
[140] D. Smith,et al. Effect of steroids and the estrous cycle on uterine neuromedin U receptor expression , 1999, Peptides.
[141] A. Howard,et al. Cloning and characterization of a human and murine T-cell orphan G-protein-coupled receptor similar to the growth hormone secretagogue and neurotensin receptors. , 1998, Genomics.
[142] S. Bloom,et al. Cloning and characterization of the cDNA encoding the human neuromedin U (NmU) precursor: NmU expression in the human gastrointestinal tract. , 1995, Journal of molecular endocrinology.
[143] J. Warchoł,et al. Effects of neuromedin U-8 on the secretory activity of the rat adrenal cortex: evidence for an indirect action requiring the presence of the zona medullaris , 1994, Research in experimental medicine. Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimenteller Chirurgie.
[144] G. Mazzocchi,et al. Effects of neuromedin U-8 on the rat pituitary-adrenocortical axis. , 1993, In Vivo.
[145] D. Smith,et al. Characterization of the rat uterine neuromedin U receptor. , 1993, Endocrinology.
[146] A. Aitken,et al. The purification and sequence analysis of an avian neuromedin U , 1992, Regulatory Peptides.
[147] H. Masui,et al. Agonistic and antagonistic activities of neuromedin U-8 analogs substituted with glycine or D-amino acid on contractile activity of chicken crop smooth muscle preparations. , 1991, Chemical and pharmaceutical bulletin.
[148] T. Hashimoto,et al. Structure-activity relationships of rat neuromedin U for smooth muscle contraction. , 1991, Chemical & pharmaceutical bulletin.
[149] P. Abel,et al. Primary structure and pharmacological activity of a nonapeptide related to neuromedin U isolated from chicken intestine , 1991, Peptides.
[150] L. Thim,et al. Rabbit neuromedin U-25: lack of conservation of a posttranslational processing site , 1991, Regulatory Peptides.
[151] P. Abel,et al. Isolation, structural characterization and pharmacological activity of dog neuromedin U , 1991, Peptides.
[152] J. Domin,et al. The motor effect of neuromedin U on rat stomach in vitro. , 1991, European journal of pharmacology.
[153] A. Giraud,et al. Isolation and microsequence analysis of a novel form of neuromedin U from guinea pig small intestine , 1990, Peptides.
[154] C. Maggi,et al. Motor response of the human isolated small intestine and urinary bladder to porcine neuromedin U‐8 , 1990, British journal of pharmacology.
[155] S. Gardiner,et al. Regional hemodynamic effects of neuromedin U in conscious rats. , 1990, The American journal of physiology.
[156] Y. Yiangou,et al. The distribution, purification, and pharmacological action of an amphibian neuromedin U. , 1989, The Journal of biological chemistry.
[157] J. Polak,et al. The Distribution and Biological Effects of Neuromedins B and U , 1988, Annals of the New York Academy of Sciences.
[158] N. Minamino,et al. Isolation and structural determination of rat neuromedin U. , 1988, Biochemical and biophysical research communications.
[159] L. Thim,et al. Primary Structure of Neuromedin U from the Rat , 1988, Journal of neurochemistry.
[160] S. Sumi,et al. Effect of synthetic neuromedin U-8 and U-25, novel peptides identified in porcine spinal cord, on splanchnic circulation in dogs. , 1987, Life sciences.
[161] M. Ghatei,et al. Characterization of neuromedin U like immunoreactivity in rat, porcine, guinea-pig and human tissue extracts using a specific radioimmunoassay. , 1986, Biochemical and biophysical research communications.
[162] N. Minamino,et al. Neuromedin U-8 and U-25: novel uterus stimulating and hypertensive peptides identified in porcine spinal cord. , 1985, Biochemical and biophysical research communications.